HEADER TRANSFERASE 31-AUG-00 1FPU TITLE CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL TITLE 2 MOLECULE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: P150, C-ABL; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS KINASE, KINASE INHIBITOR, STI-571, ACTIVATION LOOP, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.SCHINDLER,W.BORNMANN,P.PELLICENA,W.T.MILLER,B.CLARKSON,J.KURIYAN REVDAT 5 13-MAR-24 1FPU 1 COMPND SOURCE REVDAT 4 07-FEB-24 1FPU 1 REMARK SEQADV REVDAT 3 24-FEB-09 1FPU 1 VERSN REVDAT 2 30-SEP-03 1FPU 1 DBREF REVDAT 1 20-SEP-00 1FPU 0 JRNL AUTH T.SCHINDLER,W.BORNMANN,P.PELLICENA,W.T.MILLER,B.CLARKSON, JRNL AUTH 2 J.KURIYAN JRNL TITL STRUCTURAL MECHANISM FOR STI-571 INHIBITION OF ABELSON JRNL TITL 2 TYROSINE KINASE. JRNL REF SCIENCE V. 289 1938 2000 JRNL REFN ISSN 0036-8075 JRNL PMID 10988075 JRNL DOI 10.1126/SCIENCE.289.5486.1938 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 99.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 24122 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2383 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4294 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 TIGHT, NONCRYSTALLOGRAPHIC RESTRAINTS WERE UTILIZED THROUGHOUT THE REMARK 3 REFINEMENT SO THAT THE FINAL R.M.S. DEVIATION BETWEEN THE TWO REMARK 3 MOLECULES IS 0.05 AND 0.04 ANGSTROM FOR THE N-TERMINAL AND THE C- REMARK 3 TERMINAL LOBES, RESPECTIVELY (EXCLUDING RESIDUES 229 TO 337, 252, REMARK 3 262, 271, 294, 306, 404, 447, 450, 466, AND 491, WHICH WERE BUILT REMARK 3 IN DIFFERENT CONFORMATIONS IN THE TWO MOLECULES). REMARK 3 THE ELECTRON DENSITY MAP WAS SIGNIFICANTLY REMARK 3 WEAKER FOR ONE OF THE TWO MOLECULES IN THE REMARK 3 ASYMMETRIC UNIT (CHAIN ID B), AND ALL THE REMARK 3 ANALYSIS (CF. PRIMARY CITATION) RELIED ON REMARK 3 THE BETTER-ORDERED ONE (CHAIN ID A). REMARK 4 REMARK 4 1FPU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-00. REMARK 100 THE DEPOSITION ID IS D_1000011798. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-SEP-99 REMARK 200 TEMPERATURE (KELVIN) : 103 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9393 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS - B4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 221636 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 9.300 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 30.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.21600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, MAGNESIUM CHLORIDE, MES, PH REMARK 280 6.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: F 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z+1/2 REMARK 290 7555 -X,Y+1/2,-Z+1/2 REMARK 290 8555 X,-Y+1/2,-Z+1/2 REMARK 290 9555 X+1/2,Y,Z+1/2 REMARK 290 10555 -X+1/2,-Y,Z+1/2 REMARK 290 11555 -X+1/2,Y,-Z+1/2 REMARK 290 12555 X+1/2,-Y,-Z+1/2 REMARK 290 13555 X+1/2,Y+1/2,Z REMARK 290 14555 -X+1/2,-Y+1/2,Z REMARK 290 15555 -X+1/2,Y+1/2,-Z REMARK 290 16555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 73.05000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 76.40000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 73.05000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 76.40000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 73.05000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 76.40000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 73.05000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 76.40000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 76.40000 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 76.40000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 76.40000 REMARK 290 SMTRY1 12 1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 12 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 76.40000 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 73.05000 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 14 -1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 73.05000 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 15 -1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 15 0.000000 1.000000 0.000000 73.05000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 16 1.000000 0.000000 0.000000 55.35000 REMARK 290 SMTRY2 16 0.000000 -1.000000 0.000000 73.05000 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE TWO KINASE MOLECULES IN THE ASYMMETRIC UNIT. THE REMARK 300 BIOLOGICAL ASSEMBLY IS A MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 223 REMARK 465 ALA A 224 REMARK 465 SER A 500 REMARK 465 SER A 501 REMARK 465 ILE A 502 REMARK 465 SER A 503 REMARK 465 ASP A 504 REMARK 465 GLU A 505 REMARK 465 VAL A 506 REMARK 465 GLU A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 GLY A 511 REMARK 465 LYS A 512 REMARK 465 ARG A 513 REMARK 465 GLY A 514 REMARK 465 THR A 515 REMARK 465 GLY B 223 REMARK 465 ALA B 224 REMARK 465 LEU B 387 REMARK 465 MET B 388 REMARK 465 THR B 389 REMARK 465 GLY B 390 REMARK 465 ASP B 391 REMARK 465 SER B 500 REMARK 465 SER B 501 REMARK 465 ILE B 502 REMARK 465 SER B 503 REMARK 465 ASP B 504 REMARK 465 GLU B 505 REMARK 465 VAL B 506 REMARK 465 GLU B 507 REMARK 465 LYS B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 465 GLY B 511 REMARK 465 LYS B 512 REMARK 465 ARG B 513 REMARK 465 GLY B 514 REMARK 465 THR B 515 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 226 CG OD1 OD2 REMARK 470 SER A 229 OG REMARK 470 PRO A 230 CG CD REMARK 470 ASN A 231 CG OD1 ND2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 GLU A 275 CG CD OE1 OE2 REMARK 470 ASP A 276 CG OD1 OD2 REMARK 470 THR A 277 OG1 CG2 REMARK 470 MET A 278 CG SD CE REMARK 470 GLU A 279 CG CD OE1 OE2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 294 CG CD CE NZ REMARK 470 THR A 306 OG1 CG2 REMARK 470 ARG A 307 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 308 CG CD OE1 OE2 REMARK 470 LEU A 387 CG CD1 CD2 REMARK 470 MET A 388 CG SD CE REMARK 470 THR A 389 OG1 CG2 REMARK 470 ASP A 391 CG OD1 OD2 REMARK 470 THR A 394 OG1 CG2 REMARK 470 LYS A 415 CG CD CE NZ REMARK 470 GLU A 450 CG CD OE1 OE2 REMARK 470 GLU A 466 CG CD OE1 OE2 REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 GLN A 491 CG CD OE1 NE2 REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 SER B 229 OG REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 GLU B 275 CG CD OE1 OE2 REMARK 470 ASP B 276 CG OD1 OD2 REMARK 470 THR B 277 OG1 CG2 REMARK 470 MET B 278 CG SD CE REMARK 470 GLU B 279 CG CD OE1 OE2 REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 ARG B 307 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 THR B 394 OG1 CG2 REMARK 470 LYS B 415 CG CD CE NZ REMARK 470 GLU B 466 CG CD OE1 OE2 REMARK 470 LYS B 467 CG CD CE NZ REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 GLN B 498 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 229 143.66 165.50 REMARK 500 LYS A 245 -130.27 -113.83 REMARK 500 LYS A 247 163.31 -43.57 REMARK 500 GLN A 252 117.12 47.58 REMARK 500 GLU A 255 45.69 -90.26 REMARK 500 LYS A 262 -62.92 -26.07 REMARK 500 LYS A 274 -36.28 -136.76 REMARK 500 VAL A 280 -61.41 -9.70 REMARK 500 ARG A 307 -87.59 -111.61 REMARK 500 PRO A 309 -104.54 -49.75 REMARK 500 PRO A 310 88.92 -32.41 REMARK 500 ARG A 362 -12.71 77.96 REMARK 500 ASP A 363 47.16 -147.86 REMARK 500 MET A 388 99.08 -23.95 REMARK 500 ALA A 397 75.92 53.31 REMARK 500 SER B 229 135.87 -28.06 REMARK 500 PRO B 230 38.40 -74.69 REMARK 500 ASN B 231 58.91 176.91 REMARK 500 LYS B 245 -130.31 -114.01 REMARK 500 LYS B 247 164.12 -42.23 REMARK 500 GLN B 252 114.81 48.72 REMARK 500 GLU B 255 40.54 -93.07 REMARK 500 LYS B 274 -35.30 -137.13 REMARK 500 VAL B 280 -61.38 -7.26 REMARK 500 ARG B 307 -88.21 -110.89 REMARK 500 PRO B 309 -104.90 -49.75 REMARK 500 PRO B 310 88.11 -31.81 REMARK 500 ARG B 362 -10.82 76.84 REMARK 500 ASP B 363 45.99 -148.52 REMARK 500 ALA B 397 75.11 53.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PRC A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PRC B 2 DBREF 1FPU A 229 515 UNP P00520 ABL1_MOUSE 229 515 DBREF 1FPU B 229 515 UNP P00520 ABL1_MOUSE 229 515 SEQADV 1FPU GLY A 223 UNP P00520 CLONING ARTIFACT SEQADV 1FPU ALA A 224 UNP P00520 CLONING ARTIFACT SEQADV 1FPU MET A 225 UNP P00520 CLONING ARTIFACT SEQADV 1FPU ASP A 226 UNP P00520 CLONING ARTIFACT SEQADV 1FPU PRO A 227 UNP P00520 CLONING ARTIFACT SEQADV 1FPU SER A 228 UNP P00520 CLONING ARTIFACT SEQRES 1 A 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 A 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 A 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 A 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 A 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 A 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 A 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 A 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 A 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 A 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 A 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 A 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 A 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 A 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 A 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 A 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 A 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 A 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 A 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 A 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 A 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 A 293 GLU LEU GLY LYS ARG GLY THR SEQRES 1 B 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 B 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 B 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 B 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 B 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 B 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 B 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 B 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 B 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 B 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 B 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 B 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 B 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 B 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 B 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 B 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 B 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 B 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 B 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 B 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 B 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 B 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 B 293 GLU LEU GLY LYS ARG GLY THR HET PRC A 1 29 HET PRC B 2 29 HETNAM PRC N-[4-METHYL-3-[[4-(3-PYRIDINYL)-2- HETNAM 2 PRC PYRIMIDINYL]AMINO]PHENYL]-3-PYRIDINECARBOXAMIDE FORMUL 3 PRC 2(C22 H18 N6 O) FORMUL 5 HOH *99(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 LYS A 263 SER A 265 5 3 HELIX 3 3 GLU A 279 GLU A 292 1 14 HELIX 4 4 ASN A 322 CYS A 330 1 9 HELIX 5 5 SER A 336 LYS A 357 1 22 HELIX 6 6 ALA A 365 ARG A 367 5 3 HELIX 7 7 GLU A 373 HIS A 375 5 3 HELIX 8 8 GLY A 383 LEU A 387 5 5 HELIX 9 9 PRO A 402 THR A 406 5 5 HELIX 10 10 ALA A 407 TYR A 413 1 7 HELIX 11 11 SER A 417 THR A 434 1 18 HELIX 12 12 ASP A 444 SER A 446 5 3 HELIX 13 13 GLN A 447 LYS A 454 1 8 HELIX 14 14 PRO A 465 TRP A 476 1 12 HELIX 15 15 ASN A 479 ARG A 483 5 5 HELIX 16 16 SER A 485 PHE A 497 1 13 HELIX 17 17 GLU B 238 THR B 240 5 3 HELIX 18 18 GLU B 279 GLU B 292 1 14 HELIX 19 19 ASN B 322 CYS B 330 1 9 HELIX 20 20 SER B 336 LYS B 357 1 22 HELIX 21 21 ALA B 365 ARG B 367 5 3 HELIX 22 22 GLU B 373 HIS B 375 5 3 HELIX 23 23 PRO B 402 THR B 406 5 5 HELIX 24 24 ALA B 407 TYR B 413 1 7 HELIX 25 25 SER B 417 THR B 434 1 18 HELIX 26 26 ASP B 444 SER B 446 5 3 HELIX 27 27 GLN B 447 LYS B 454 1 8 HELIX 28 28 PRO B 465 TRP B 476 1 12 HELIX 29 29 ASN B 479 ARG B 483 5 5 HELIX 30 30 SER B 485 PHE B 497 1 13 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N LYS A 245 SHEET 3 A 5 THR A 267 LEU A 273 -1 N VAL A 268 O GLY A 259 SHEET 4 A 5 PHE A 311 GLU A 316 -1 N PHE A 311 O LEU A 273 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 2 CYS A 369 VAL A 371 0 SHEET 2 B 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 2 THR A 394 HIS A 396 0 SHEET 2 C 2 ALA A 399 PHE A 401 -1 O ALA A 399 N HIS A 396 SHEET 1 D 5 ILE B 242 LYS B 247 0 SHEET 2 D 5 VAL B 256 TRP B 261 -1 N GLU B 258 O HIS B 246 SHEET 3 D 5 THR B 267 LYS B 271 -1 N VAL B 268 O GLY B 259 SHEET 4 D 5 TYR B 312 GLU B 316 -1 O ILE B 313 N LYS B 271 SHEET 5 D 5 LEU B 301 CYS B 305 -1 N LEU B 302 O ILE B 314 SHEET 1 E 2 CYS B 369 VAL B 371 0 SHEET 2 E 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 F 2 THR B 394 HIS B 396 0 SHEET 2 F 2 ALA B 399 PHE B 401 -1 O ALA B 399 N HIS B 396 SITE 1 AC1 15 LEU A 248 TYR A 253 ALA A 269 LYS A 271 SITE 2 AC1 15 GLU A 286 MET A 290 VAL A 299 ILE A 313 SITE 3 AC1 15 THR A 315 PHE A 317 MET A 318 ALA A 380 SITE 4 AC1 15 ASP A 381 PHE A 382 HOH A 531 SITE 1 AC2 15 LEU B 248 VAL B 256 LYS B 271 GLU B 286 SITE 2 AC2 15 MET B 290 VAL B 299 ILE B 313 THR B 315 SITE 3 AC2 15 PHE B 317 MET B 318 LEU B 370 ALA B 380 SITE 4 AC2 15 ASP B 381 PHE B 382 HOH B 543 CRYST1 110.700 146.100 152.800 90.00 90.00 90.00 F 2 2 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009033 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006845 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006545 0.00000